MBX Biosciences Inc
MBX12.280USD
-1.470-10.69%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
410.45MMarket Cap
LossP/E TTM
MBX Biosciences Inc
12.280
-1.470-10.69%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-111.75%-22.68M
-43.88%-16.04M
-89.80%-14.66M
-79.79%-13.27M
-87.07%-10.71M
---11.15M
---7.73M
---7.38M
---5.72M
Net income from continuing operations
-93.56%-23.88M
-76.25%-15.59M
-78.51%-18.14M
-108.43%-15.86M
-107.38%-12.34M
---8.84M
---10.16M
---7.61M
---5.95M
Operating gains losses
60.42%77.00K
41.46%58.00K
87.50%75.00K
61.54%63.00K
29.73%48.00K
--41.00K
--40.00K
--39.00K
--37.00K
Other non-cash items
-174.90%-1.31M
-138.26%-1.37M
-6322.22%-560.00K
-197.84%-414.00K
-95.90%-478.00K
---575.00K
--9.00K
---139.00K
---244.00K
Change in working capital
38.25%600.00K
78.05%-627.00K
54.63%2.77M
1879.41%2.02M
91.19%434.00K
---2.86M
--1.79M
--102.00K
--227.00K
-Change in prepaid expenses
303.92%1.65M
22.16%-1.03M
-562.60%-569.00K
-687.76%-1.16M
36.45%408.00K
---1.32M
--123.00K
---147.00K
--299.00K
-Change in other current assets
----
----
----
--0.00
--0.00
---8.00K
----
--0.00
--0.00
Cash from non-recurring investing activities
Cash from operating activities
-111.75%-22.68M
-43.88%-16.04M
-89.80%-14.66M
-79.79%-13.27M
-87.07%-10.71M
---11.15M
---7.73M
---7.38M
---5.72M
Investing cash flow
Net cash from continuing investing activities
-89.01%30.00K
67.27%92.00K
159.09%57.00K
1358.06%452.00K
1200.00%273.00K
--55.00K
--22.00K
--31.00K
--21.00K
Capital expenditures
-89.01%30.00K
67.27%92.00K
159.09%57.00K
1358.06%452.00K
1200.00%273.00K
--55.00K
--22.00K
--31.00K
--21.00K
Net cash flow from disposal of fixed assets
-89.01%30.00K
67.27%92.00K
159.09%57.00K
1358.06%452.00K
1200.00%273.00K
--55.00K
--22.00K
--31.00K
--21.00K
Net cash flow from investment products
-79.26%3.26M
-132.71%-67.25M
-442.06%-100.73M
-137.19%-7.44M
573.67%15.70M
---28.90M
---18.58M
--20.00M
---3.31M
Cash from non-current investing activities
Net cash flow from investing activities
-79.09%3.23M
-132.59%-67.34M
-441.73%-100.79M
-139.52%-7.89M
562.50%15.43M
---28.95M
---18.61M
--19.97M
---3.34M
Financing cash flow
Cash flow from continuous financing activities
-97.81%4.00K
-794.74%-132.00K
244.27%235.81M
-377.76%-1.76M
165.22%183.00K
--19.00K
--68.50M
--634.00K
--69.00K
Net cash flow from debt Issuance/repayment
----
----
----
----
----
--0.00
----
----
----
Net cash flow from common stock issuance/repurchase
----
--0.00
--174.54M
----
----
--0.00
--0.00
----
----
Net cash flow from preferred stock issuance/repurchase
----
--0.00
-7.31%63.50M
----
----
--0.00
--68.51M
----
----
Proceeds from stock option exercised by employees
-97.88%4.00K
926.32%195.00K
-282.35%-31.00K
-92.11%50.00K
173.91%189.00K
--19.00K
--17.00K
--634.00K
--69.00K
Net cash flow from other financing activities
100.00%0.00
---327.00K
-7223.33%-2.20M
---1.81M
---6.00K
--0.00
---30.00K
--0.00
--0.00
Net cash from non-recurrent financing activities
Net cash from financing activities
-97.81%4.00K
-794.74%-132.00K
244.27%235.81M
-377.76%-1.76M
165.22%183.00K
--19.00K
--68.50M
--634.00K
--69.00K
Net cash flow
Beginning cash balance
61.68%49.35M
88.18%132.87M
-56.04%12.50M
132.78%35.42M
26.08%30.52M
--70.61M
--28.44M
--15.22M
--24.21M
Current period cash flow changes
-496.74%-19.45M
-108.36%-83.51M
185.45%120.36M
-273.36%-22.92M
154.52%4.90M
---40.08M
--42.16M
--13.22M
---8.99M
Ending cash balance
-15.59%29.90M
61.68%49.35M
88.18%132.87M
-56.04%12.50M
132.78%35.42M
--30.52M
--70.61M
--28.44M
--15.22M
Free cash flow
-106.76%-22.71M
-44.00%-16.13M
-90.00%-14.72M
-85.13%-13.72M
-91.14%-10.98M
---11.20M
---7.75M
---7.41M
---5.75M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
